Owner Sanofi

Inventors Ruf, Sven; Pernerstorfer, Josef; Sadowski, Thorsten; Horstick, Georg; Schreuder, Herman; Buning, Christian; Olpp, Thomas; Scheiper, Bodo; Wirth, Klaus

Agent Watermark

Pub. Number AU-A-2011209333

PCT Pub. Number WO2011/092187

Priority 61/309,119 01.03.10 US; 10305080.3 26.01.10 EP

Filing date 26 January 2011

Wipo publication date 4 August 2011

C07D 231/20 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 - 1,2-Diazoles

A61P 9/00 Drugs for disorders of the cardiovascular system

A61P 11/00 Drugs for disorders of the respiratory system

A61P 13/12 Drugs for disorders of the urinary system

A61P 25/28 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 Drugs for immunological or allergic disorders

C07D 231/22 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group